Target intelligence / Profile preview

SIGLEC10 antisense RNA 2 (SIGLEC10-AS2)

Target
SIGLEC10-AS2
Molecular classification
Other, Long non-coding RNA, Antisense RNA
01

Overview

SIGLEC10 antisense RNA 2 (SIGLEC10-AS2, also known as AC008750.1) is a long non-coding RNA gene, transcribed antisense to the protein-coding gene SIGLEC10[4][7]. Antisense RNAs are typically non-protein-coding transcripts that regulate the expression of nearby or overlapping genes, often by mechanisms such as transcriptional interference, mRNA stabilization/destabilization, or recruitment of chromatin modifiers[6][9]. There is currently no evidence that SIGLEC10-AS2 acts as a receptor, enzyme, or classical therapeutic target, nor are there drugs or specific disease roles associated with this RNA in the literature to date[4][7]. Most functional data for antisense RNAs in general relate to post-transcriptional or transcriptional regulation, but details for SIGLEC10-AS2 itself remain uncharacterized[4][7]. This entry is therefore a long non-coding RNA with regulatory potential but does not currently qualify as a direct therapeutic target.

Other names
AC008750.1
02

Biological functions

Gene expression regulation

Beyond the preview

Go deeper on SIGLEC10 antisense RNA 2 (SIGLEC10-AS2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SIGLEC10 antisense RNA 2 (SIGLEC10-AS2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call